Ophthalmologists are struggling to obtain a biologic to treat macular degeneration, and some insurers are allegedly promoting off-label use of biosimilars for patients.
from Section Page News - Modern Healthcare https://ift.tt/37s5ufW
Thursday, August 5, 2021
Health insurers allegedly use biologic shortage to promote biosimilarsHealth insurers allegedly use biologic shortage to promote biosimilarsHealth insurers allegedly use biologic shortage to promote biosimilars
Health insurers allegedly use biologic shortage to promote biosimilars
from Section Page News - Modern Healthcare https://ift.tt/37s5ufW
from Section Page News - Modern Healthcare https://ift.tt/37s5ufW
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment